Trump Strives to End HIV, But at Whose Expense?
A Plan for America
The Trump administration strives to end the HIV epidemic, but at whose expense?
by Jeannie Wraight
In this month’s Destination: Cure I’m going...
JAK Inhibitors
JAK of All Trades
Researchers look to JAK inhibitors as part of hiv treatment & eradication
by Jeannie Wraight
R research on three Janus kinase inhibitors (JAK...
Cure Research: CROI 2018
Fast Look
Cure research highlights from CROI 2018
by Jeannie Wraight
The Conference on Retroviruses and Opportunistic Infections (CROI) provides an annual snapshot of the year’s most...
BIT225: HIV VPU Inhibitor Candidate
Contender in the Ring
A novel HIV therapy targets & eradicates one cell type in the viral reservoir
by Jeannie Wraight
BIT225, an HIV VPU inhibitor, has...
Targeting HIV Reservoirs
Hiding Place
One focus of the amfAR 2016 CURE Summit targeted HIV reservoirs
by Jeannie Wraight
This year, amfAR marked World AIDS Day with the 2016 HIV...
How COVID Research Is Impacting HIV Cure Research
How COVID Research Is Impacting HIV Cure Research
The Pressure Is Mounting for the BEAT HIV Team to Beat the Clock Before Time & Funding...
Post-Treatment Controllers & HIV Treatment
Control Issues
What can post-treatment controllers tell us about HIV care and treatment?
by Jeannie Wraight
In order to keep their virus suppressed, most people living with...
Translation Inhibitors as Therapeutic Strategy
Cure Research with a Heart
Translation inhibitors may be part of a therapeutic strategy
by Jeannie Wraight
To date there are over 100 documented cases of HIV...
Good News, Bad News
LifeGuide
Good News, Bad News
The HIV cure front faces disappointment mixed with hope
by Jeannie Wraight
The past year has been a difficult one in the HIV...
APPROACH Study
Mosaic Design
APPROACH, a preventive vaccine study, seeks to address more than one clade
by Jeannie Wraight
Over the past thirty-plus years, strategies such as Treatment as...